Skip to main content
Log in

Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Treatment of IgA nephropathy (IgAN) in Japan has recently changed, from oral prednisolone (oPSL) to tonsillectomy plus steroid pulse (TSP) therapy. However, a few studies have compared their efficacy and safety.

Methods

IgAN patients diagnosed in our institution between 1991 and 2013, treated with TSP or oPSL, aged ≥16 years, with ≥1 g/day proteinuria, and estimated glomerular filtration rate (eGFR) ≥30 ml/min/1.73 m2, and no other renal disease were selected. Baseline clinical and histological findings, clinical outcomes, and adverse events were compared. Clinical remission (CR) was defined as <0.3 g/day proteinuria and <5 urinary red blood cells per high-powered field.

Results

Sixty-six patients were identified; after propensity score adjustment, 26 patients were selected in each group. CR rates were significantly higher at 12 (30.8 % vs. 3.9 %), 36 (47.3 % vs. 7.9 %), and 72 (57.8 % vs. 20.1 %) months (p < 0.01), and the renal survival rate, defined as the development of a 25 % reduction from baseline eGFR, was significantly higher at 12 (96.2 % vs. 69.2 %), 36 (96.2 % vs. 61.5 %), and 72 (96.2 % vs. 41.0 %) months in the TSP than the oPSL group (p < 0.001). Multivariate analysis showed that TSP was the only independent factor associated with CR (hazard ratio, 3.58; 95 % confidence interval, 1.32–10.91, p = 0.01). The number of patients with adverse events was significant lower in TSP group than in oPSL group (11.5 % vs. 34.6 %, p = 0.04).

Conclusions

CR rates are higher; protection of renal function and prevention from adverse events were superior with TSP than with oPSL in patients with IgAN and moderate-to-severe proteinuria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738–48.

    Article  CAS  PubMed  Google Scholar 

  2. Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: prospective pilot study in moderate proteinuric cases. QJMed. 1986;61:935–43.

    CAS  Google Scholar 

  3. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron. 1996;72:237–42.

    Article  CAS  PubMed  Google Scholar 

  4. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet. 1999;353:883–7.

    Article  CAS  PubMed  Google Scholar 

  5. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.

    Article  CAS  PubMed  Google Scholar 

  6. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.

    Article  CAS  PubMed  Google Scholar 

  7. Miura N, Imai H, Kikuchi S, Hayashi S, Endoh M, Kawamura T, Tomino Y, Moriwaki K, Kiyomoto H, Kohagura K, Nakazawa E, Kusano E, Mochizuki T, Nomura S, Sasaki T, Kashihara N, Soma J, Tomo T, Nakabayashi I, Yoshida M, Watanabe T. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol. 2009;13:460–6.

    Article  CAS  PubMed  Google Scholar 

  8. Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y. Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol. 2013;17:827–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ochi A, Moriyama Y, Takei T, Uchida K, Nitta K. Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol. 2013;45:469–76.

    Article  CAS  PubMed  Google Scholar 

  10. Kamei D, Moriyama T, Takei T, Wakai S, Nitta K. Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol. 2014;18:320–8.

    Article  CAS  PubMed  Google Scholar 

  11. Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y. Study group special IgA nephropathy a histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol. 2013;26:350–7.

    Article  CAS  PubMed  Google Scholar 

  12. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR.Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  13. Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y, Matsuo S. Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol. 2014;18:481–6.

    Article  CAS  PubMed  Google Scholar 

  14. Sato M, Hotta O, Tomioka S, Horigome I, Chiba S, Miyazaki M, Noshiro H, Taguma Y. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract. 2003;93:c137–45.

    Article  CAS  PubMed  Google Scholar 

  15. Komatsu H, Sato Y, Miyamoto T, Tamura M, Nakata T, Tomo T, Nishino T, Miyazaki M, Fujimoto S. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2016;20:94–102.

    Article  CAS  PubMed  Google Scholar 

  16. Takechi H, Oda T, Hotta O, Yamamoto K, Oshima N, Matsunobu T, Shiotani A, Nagura H, Shimazaki H, Tamai S, Sakurai Y, Kumagai H. Clinical and immunological implications of increase in CD208 + dendritic cells in tonsils of patients with immunoglobulin A nephropathy. Nephrol Dial Transpl. 2013;28:3004–13.

    Article  CAS  Google Scholar 

  17. Bene MC, Faure G, Hurault de Ligny B, Kessler M, Duheille J. Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest. 1983;71:1342–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Migita K, Eguchi K, Kawabe Y, Nakamura T, Shirabe S, Tsukada T, Ichinose Y, Nakamura H, Nagataki S. Apoptosis of induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation. 1997;64:583–7.

    Article  Google Scholar 

  19. Hotta O. Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy. Semin Nephrol. 2004;24:244–55.

    Article  CAS  PubMed  Google Scholar 

  20. Chen Y, Tang Z, Wang Q, Yu Y, Zeng C, Chen H, Liu ZH, Li LS. Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol. 2007;27:170–5.

    Article  PubMed  Google Scholar 

  21. Akagi H, Kosaka M, Hattori K, Doi A, Fukushima K, Okano M, Kariya S, Nishizaki K, Sugiyama N, Shikata K, Makino H, Masuda Y. Long-term results of tonsillectomy as a treatment for IgA nephropathy. Acta Otolaryngol. 2004;555:38–42.

    Article  Google Scholar 

  22. Wang Y, Chen J, Wang Y, Chen Y, Wang L, Lv Y. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:1923–31.

    Article  CAS  PubMed  Google Scholar 

  23. Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9:e91756.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kawasaki Y, Suyama K, Abe Y, Ushijima Y, Sakai N, Takano K, Ito M, Hashimoto K, Hosoya M. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid resistant IgA nephropathy in children. Tohoku J Exp Med. 2009;218:11–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takahito Moriyama.

Ethics declarations

Conflict of interest

The authors report no disclosures or conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number #3738) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

“Informed consent for renal biopsy was obtained from all individual participants included in the study.”

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoshino, Y., Moriyama, T., Uchida, K. et al. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy. Clin Exp Nephrol 21, 617–623 (2017). https://doi.org/10.1007/s10157-016-1324-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-016-1324-2

Keywords

Navigation